Clinical Lab Automation Market Trends
Increasing Applications of Next-Generation Sequencing Technology
Next-generation sequencing (NGS) technology has drastically reduced the cost of DNA sequencing and revolutionized genetic disease diagnostics with its rapid, high-throughput, and cost-effective approaches. NGS enables simultaneous analysis of hundreds of genes, the whole exome, and the whole genome, offering profound insights into unknown species and complex diseases.
NGS technology has gained substantial traction in diagnosing infectious diseases, immunological disorders, and hereditary conditions. It is also widely used for non-invasive prenatal diagnosis and therapeutic decision-making for somatic cancers. The use of automated NGS instruments in clinical diagnostics offers numerous benefits, including shorter turnaround times, minimal manual intervention, and reduced risk of contamination, thereby enhancing diagnostic accuracy and efficiency.
Incorporation of Artificial Intelligence (AI) in Automated Instruments
Clinical laboratories are increasingly integrating artificial intelligence (AI) to manage incomplete and imprecise information. AI facilitates workflows, enhances operational decision-making, and reduces the reliance on human professionals. For instance, in September 2022, GE Healthcare (U.S.) launched its first 'Made in India' AI-powered Cath Lab – Optima IGS 320, which provides advanced cardiac care. This technology uses AI to optimize image and dose parameters in real-time, allowing clinicians to focus more on patient care.
AI can also be utilized for quality control, predictive analytics, and data integration in laboratories, thereby increasing the demand for clinical lab automation instruments and driving market growth.
Clinical Lab Automation Market Opportunity
Use of Clinical Lab Automation in Emerging Economies
The quality of healthcare in emerging economies is improving significantly due to the adoption of automated instruments in clinical laboratories and hospitals, despite limited resources and funding. According to the Ministry of Health & Family Welfare of the Government of India, the total number of tuberculosis patients in 2021 was 1,933,381, compared to 1,628,161 in 2020. In November 2022, MyLab Discovery Solutions Pvt Ltd. (India) received CDSCO, TB Expert Committee, and ICMR approval for a Made in India TB Detection Kit that uses the automated MyLab Compact device, allowing for the complete automated testing of multiple samples within two hours.
Such advancements in developing economies create significant opportunities for clinical lab automation instruments and services, driving market growth.
Clinical Lab Automation Market Analysis: Key Findings
By Product: In 2024, the Systems Segment to Dominate the Clinical Lab Automation Market
Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2024, the systems segment is expected to account for the largest share, at 84.3%, of the clinical lab automation market. This dominance is attributed to the benefits of clinical lab automation systems, which streamline procedures without manual intervention, enhancing laboratory testing capabilities. These systems mitigate repetitive tasks and errors, increasing throughput and efficiency, and ultimately improving the quality of test results.
By End User: In 2024, the Hospital Laboratories Segment to Dominate the Clinical Lab Automation Market
Based on end users, the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2024, the hospital laboratories segment is expected to account for the largest share, at 49.6%, of the clinical lab automation market. Hospital laboratories are increasingly adopting automation to minimize human intervention in laboratory procedures. Automation enhances the ordering, testing, and reporting of diagnostic tests in hospitals. The rising healthcare expenditures, increasing prevalence of chronic diseases, growing sample loads, and improving healthcare infrastructure in developing countries drive the demand for lab automation systems, contributing to the large market share of this segment.
Key Players
The key players profiled in the clinical lab automation market report are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the clinical lab automation market, followed by Europe. However, Asia Pacific is slated to register the largest CAGR during the forecast period. The growth of this market is primarily driven by the increasing investment by healthcare providers towards infrastructure improvement, the need to manage the growing burden of infectious diseases, the rising demand for clinical testing, supportive government initiatives to improve the accessibility to diagnostic services, and the need to establish more diagnostic laboratories.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5762
Key questions answered in the report-
· Which are the high-growth market segments in terms of product, end user, and region/country?
· What was the historical market for clinical lab automation across the globe?
· What are the market forecasts and estimates for the period 2024–2031?
· What are the major drivers, restraints, challenges, opportunities, and trends in the global market of clinical lab automation?
· Who are the major players in the global clinical lab automation market?
· What is the competitive landscape like, and who are the market leaders in the global clinical lab automation market?
· What are the recent developments in the clinical lab automation market?
· What are the different strategies adopted by the major players in the clinical lab automation market?
· What are the geographical trends and high growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
